Literature DB >> 28935667

Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.

Toshie Saito1,2,3, Kazuya Miyagawa1,2,3, Shih-Yu Chen4,5, Rasa Tamosiuniene1,2,6, Lingli Wang1,2,3, Orr Sharpe6, Erik Samayoa7, Daisuke Harada6, Jan-Renier A J Moonen1,2,3, Aiqin Cao1,2,3, Pin-I Chen1,2,3, Jan K Hennigs1,2,3, Mingxia Gu1,2,3, Caiyun G Li1,2,3, Ryan D Leib, Dan Li1,2,3, Christopher M Adams, Patricia A Del Rosario1,6, Matthew Bill1,6, Francois Haddad2,6, Jose G Montoya6, William H Robinson6, Wendy J Fantl4,5,8, Garry P Nolan4,5, Roham T Zamanian1,2,6, Mark R Nicolls1,2,6, Charles Y Chiu7, Maria E Ariza9, Marlene Rabinovitch10,2,3.   

Abstract

BACKGROUND: Immune dysregulation has been linked to occlusive vascular remodeling in pulmonary arterial hypertension (PAH) that is hereditary, idiopathic, or associated with other conditions. Circulating autoantibodies, lung perivascular lymphoid tissue, and elevated cytokines have been related to PAH pathogenesis but without a clear understanding of how these abnormalities are initiated, perpetuated, and connected in the progression of disease. We therefore set out to identify specific target antigens in PAH lung immune complexes as a starting point toward resolving these issues to better inform future application of immunomodulatory therapies.
METHODS: Lung immune complexes were isolated and PAH target antigens were identified by liquid chromatography tandem mass spectrometry, confirmed by enzyme-linked immunosorbent assay, and localized by confocal microscopy. One PAH antigen linked to immunity and inflammation was pursued and a link to PAH pathophysiology was investigated by next-generation sequencing, functional studies in cultured monocytes and endothelial cells, and hemodynamic and lung studies in a rat.
RESULTS: SAM domain and HD domain-containing protein 1 (SAMHD1), an innate immune factor that suppresses HIV replication, was identified and confirmed as highly expressed in immune complexes from 16 hereditary and idiopathic PAH versus 12 control lungs. Elevated SAMHD1 was localized to endothelial cells, perivascular dendritic cells, and macrophages, and SAMHD1 antibodies were prevalent in tertiary lymphoid tissue. An unbiased screen using metagenomic sequencing related SAMHD1 to increased expression of human endogenous retrovirus K (HERV-K) in PAH versus control lungs (n=4). HERV-K envelope and deoxyuridine triphosphate nucleotidohydrolase mRNAs were elevated in PAH versus control lungs (n=10), and proteins were localized to macrophages. HERV-K deoxyuridine triphosphate nucleotidohydrolase induced SAMHD1 and proinflammatory cytokines (eg, interleukin 6, interleukin 1β, and tumor necrosis factor α) in circulating monocytes, pulmonary arterial endothelial cells, and also activated B cells. Vulnerability of pulmonary arterial endothelial cells (PAEC) to apoptosis was increased by HERV-K deoxyuridine triphosphate nucleotidohydrolase in an interleukin 6-independent manner. Furthermore, 3 weekly injections of HERV-K deoxyuridine triphosphate nucleotidohydrolase induced hemodynamic and vascular changes of pulmonary hypertension in rats (n=8) and elevated interleukin 6.
CONCLUSIONS: Our study reveals that upregulation of the endogenous retrovirus HERV-K could both initiate and sustain activation of the immune system and cause vascular changes associated with PAH.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  SAM domain and HD domain-containing protein 1 (SAMHD1); deoxyuridine triphosphate nucleotidohydrolase (dUTPase); human endogenous retrovirus K (HERV-K); pulmonary arterial hypertension (PAH); tertiary lymphoid tissue

Mesh:

Substances:

Year:  2017        PMID: 28935667      PMCID: PMC5685911          DOI: 10.1161/CIRCULATIONAHA.117.027589

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  50 in total

Review 1.  SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection.

Authors:  Alexandre Sze; David Olagnier; Rongtuan Lin; Julien van Grevenynghe; John Hiscott
Journal:  J Mol Biol       Date:  2013-10-23       Impact factor: 5.469

2.  Human γ-herpesviruses Epstein-Barr virus and human herpesvirus-8 are not detected in the lungs of patients with severe pulmonary arterial hypertension.

Authors:  Séverine Valmary; Peter Dorfmüller; David Montani; Marc Humbert; Pierre Brousset; Bruno Degano
Journal:  Chest       Date:  2010-11-04       Impact factor: 9.410

3.  Haplotype sharing analysis identifies a retroviral dUTPase as candidate susceptibility gene for psoriasis.

Authors:  John Foerster; Ilja Nolte; Judith Junge; Marcel Bruinenberg; Susann Schweiger; Katja Spaar; Gerrit van der Steege; Claudia Ehlert; Marcel Mulder; Vera Kalscheuer; Elisa Blumenthal-Barby; Jennifer Winter; Petra Seeman; Markward Ständer; Wolfram Sterry; Gerard Te Meerman
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

4.  Expression analyses of human endogenous retroviruses (HERVs): tissue-specific and developmental stage-dependent expression of HERVs.

Authors:  Goichi Okahara; Shinobu Matsubara; Takaya Oda; Jun Sugimoto; Yoshihiro Jinno; Fuminori Kanaya
Journal:  Genomics       Date:  2004-12       Impact factor: 5.736

Review 5.  Lymphoid neogenesis in chronic inflammatory diseases.

Authors:  Francesca Aloisi; Ricardo Pujol-Borrell
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

6.  Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus.

Authors:  Rudolf Pullmann; Eduardo Bonilla; Paul E Phillips; Frank A Middleton; Andras Perl
Journal:  Arthritis Rheum       Date:  2008-02

7.  HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.

Authors:  David C Goldstone; Valerie Ennis-Adeniran; Joseph J Hedden; Harriet C T Groom; Gillian I Rice; Evangelos Christodoulou; Philip A Walker; Geoff Kelly; Lesley F Haire; Melvyn W Yap; Luiz Pedro S de Carvalho; Jonathan P Stoye; Yanick J Crow; Ian A Taylor; Michelle Webb
Journal:  Nature       Date:  2011-11-06       Impact factor: 49.962

8.  Significance analysis of microarray for relative quantitation of LC/MS data in proteomics.

Authors:  Bryan A P Roxas; Qingbo Li
Journal:  BMC Bioinformatics       Date:  2008-04-10       Impact factor: 3.169

9.  SAMHD1 prevents autoimmunity by maintaining genome stability.

Authors:  Stefanie Kretschmer; Christine Wolf; Nadja König; Wolfgang Staroske; Jochen Guck; Martin Häusler; Hella Luksch; Laura A Nguyen; Baek Kim; Dimitra Alexopoulou; Andreas Dahl; Alexander Rapp; M Cristina Cardoso; Anna Shevchenko; Min Ae Lee-Kirsch
Journal:  Ann Rheum Dis       Date:  2014-01-20       Impact factor: 19.103

10.  Expression of selected human endogenous retroviral sequences in skin and peripheral blood mononuclear cells in morphea.

Authors:  Michał J Kowalczyk; Aleksandra Dańczak-Pazdrowska; Beata Szramka-Pawlak; Ryszard Zaba; Wojciech Silny; Agnieszka Osmola-Mańkowska
Journal:  Arch Med Sci       Date:  2012-10-08       Impact factor: 3.318

View more
  22 in total

1.  Update in Pulmonary Vascular Disease 2016 and 2017.

Authors:  Evan L Brittain; Thennapan Thennapan; Bradley A Maron; Stephen Y Chan; Eric D Austin; Edda Spiekerkoetter; Harm J Bogaard; Christophe Guignabert; Roxane Paulin; Roberto F Machado; Paul B Yu
Journal:  Am J Respir Crit Care Med       Date:  2018-07-01       Impact factor: 21.405

2.  Exploring New Therapeutic Pathways in Pulmonary Hypertension. Metabolism, Proliferation, and Personalized Medicine.

Authors:  M Patricia George; Mark T Gladwin; Brian B Graham
Journal:  Am J Respir Cell Mol Biol       Date:  2020-09       Impact factor: 6.914

3.  Type I interferon activation and endothelial dysfunction in caveolin-1 insufficiency-associated pulmonary arterial hypertension.

Authors:  Salina Gairhe; Keytam S Awad; Edward J Dougherty; Gabriela A Ferreyra; Shuibang Wang; Zu-Xi Yu; Kazuyo Takeda; Cumhur Y Demirkale; Parizad Torabi-Parizi; Eric D Austin; Jason M Elinoff; Robert L Danner
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

4.  Effect of hepatocyte growth factor on mice with hypoxic pulmonary arterial hypertension: a preliminary study.

Authors:  Hu-Ting Tang; Wei-Hao Mu; Yu-Jing Xiang; Yong An
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-08-15

5.  Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.

Authors:  Edda Spiekerkoetter; Elena A Goncharova; Christophe Guignabert; Kurt Stenmark; Grazyna Kwapiszewska; Marlene Rabinovitch; Norbert Voelkel; Harm J Bogaard; Brian Graham; Soni S Pullamsetti; Wolfgang M Kuebler
Journal:  Pulm Circ       Date:  2019-11-20       Impact factor: 3.017

6.  Close to the Bedside: A Systematic Review of Endogenous Retroviruses and Their Impact in Oncology.

Authors:  David F Grabski; Yinin Hu; Monika Sharma; Sara K Rasmussen
Journal:  J Surg Res       Date:  2019-03-29       Impact factor: 2.417

7.  Targeting inflammation and immunity in pulmonary arterial hypertension: any easier after the CANTOS proof-of-concept that anti-inflammation cuts cardiovascular events?

Authors:  Christian Gerges; Irene Lang
Journal:  Pulm Circ       Date:  2018-01-08       Impact factor: 3.017

Review 8.  Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease.

Authors:  Kyle A Batton; Christopher O Austin; Katelyn A Bruno; Charles D Burger; Brian P Shapiro; DeLisa Fairweather
Journal:  Biol Sex Differ       Date:  2018-04-18       Impact factor: 5.027

Review 9.  Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease.

Authors:  Karen Giménez-Orenga; Elisa Oltra
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-24

Review 10.  Role of Viruses in the Pathogenesis of Multiple Sclerosis.

Authors:  Rachael E Tarlinton; Ekaterina Martynova; Albert A Rizvanov; Svetlana Khaiboullina; Subhash Verma
Journal:  Viruses       Date:  2020-06-13       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.